ANNOUNCEMENT

MedCity CONVERGE July 9-10 in Philly gathers payers, providers, medtech, pharma, digital health, policymakers & more.

Topic: Cancer

Intel and Knight Cancer Institute want to make genetic analysis part of all patient care

Intel and Knight Cancer Institute want to make genetic analysis part of all patient care

April 26, 2013 6:49 pm by | 0 Comments

Intel and the Oregon Health & Science University are teaming up on a supercomputing project to speed up analysis of human genetic profiles, which could help with personalized treatment for ... Read more
Study: Latin America threatened by growing cancer epidemic and high mortality rates

Study: Latin America threatened by growing cancer epidemic and high mortality rates

April 26, 2013 4:10 pm by | 0 Comments

SAO PAULO (Reuters) - Latin America's growing prosperity is fueling a cancer epidemic that threatens to overwhelm the region unless governments take urgent preventive action, a study published on Friday ... Read more
Merck melanoma drug wins ‘breakthrough’ designation

Merck melanoma drug wins ‘breakthrough’ designation

April 24, 2013 11:37 am by | 0 Comments

April 24 (Reuters) - U.S. regulators have granted Merck & Co's experimental treatment for advanced melanoma a "breakthrough therapy" designation, which could speed development and regulatory review of the product.The ... Read more
Heat Biologics gets $5M to usher heat shock protein therapy into phase 2 lung cancer trials

Heat Biologics gets $5M to usher heat shock protein therapy into phase 2 lung cancer trials

April 17, 2013 4:30 pm by | 0 Comments

A company developing an off-the-shelf immunotherapy that it thinks can turn tumors into adjuvant-secreting machines has some fresh capital as it heads into phase 2 clinical trials.Twenty investors have put ... Read more
Roche’s immune therapy drug seems to work against several types of cancer

Roche’s immune therapy drug seems to work against several types of cancer

April 9, 2013 3:03 pm by | 0 Comments

April 9 (Reuters) - An experimental drug that spurs the immune system to fight cancer appeared to be safe and demonstrated anti-tumor activity against a variety of cancers in a ... Read more
India’s top court dismisses Novartis petition for Glivec patent

India’s top court dismisses Novartis petition for Glivec patent

April 1, 2013 1:17 am by | 0 Comments

NEW DELHI (Reuters) - India's highest court has dismissed Swiss drugmaker Novartis AG's petition seeking patent protection for its cancer drug Glivec, a serious blow to Western pharmaceutical firms which ... Read more
Simple math: Cut the co-pays and get more cancer screenings

Simple math: Cut the co-pays and get more cancer screenings

March 27, 2013 5:03 pm by | 0 Comments

NEW YORK (Reuters Health) - More women may get screened for breast and cervical cancers if they don't have to pay for the tests, according to a new study from ... Read more
Celgene deal boosts startup developing a way to test different cancer drugs in the same tumor

Celgene deal boosts startup developing a way to test different cancer drugs in the same tumor

March 21, 2013 12:08 pm by | 0 Comments

As part of a new research deal with Celgene Corp., a startup with intriguing technology that could someday enable personalized medicine by letting doctors test different cancer drugs in a ... Read more
State health department: Minnesota has enough radiation treatment centers

State health department: Minnesota has enough radiation treatment centers

March 16, 2013 6:17 am by | 0 Comments

Minnesota has enough radiation treatment facilities for patients, even though cancer cases are expected to grow by almost 24 percent in the next decade, according to a report released Friday ... Read more
After breast cancer, high-fat dairy foods raise risk of death

After breast cancer, high-fat dairy foods raise risk of death

March 14, 2013 4:05 pm by | 0 Comments

NEW YORK (Reuters) - Women who have ever had breast cancer might want to walk away from the brie, the butter and the black cherry (and every other flavor) ice ... Read more
This time, FDA says yes to Navidea Biopharmaceuticals’ Lymphoseek

This time, FDA says yes to Navidea Biopharmaceuticals’ Lymphoseek

March 13, 2013 5:41 pm by | 0 Comments

After more than a decade of development and a couple regulatory delays, Navidea Biopharmaceuticals (NYSE:NAVB) finally got the FDA approval it needs to begin marketing its radiopharmaceutical Lymphoseek.In a conference ... Read more
Heart risk rises with breast cancer radiation

Heart risk rises with breast cancer radiation

March 13, 2013 5:18 pm by | 0 Comments

NEW YORK (Reuters Health) - The radiation that might cure a breast cancer may also raise a woman's risk of having a heart attack or heart disease later in life, ... Read more
Generic drug market chops up Spectrum Pharmaceuticals’ Fusilev colon cancer drug

Generic drug market chops up Spectrum Pharmaceuticals’ Fusilev colon cancer drug

March 12, 2013 8:18 pm by | 1 Comments

(Reuters) - Spectrum Pharmaceuticals forecast a steep drop in full-year sales as it expects uptake of its biggest-selling product, colon cancer drug Fusilev, to significantly decline as cheaper generics re-enter ... Read more
UNC spinout wants to help health workers wipe out surface contamination by harmful cancer drugs

UNC spinout wants to help health workers wipe out surface contamination by harmful cancer drugs

March 12, 2013 11:02 am by | 0 Comments

Chemotherapy drugs used today are potent and nonselective, meaning they kill both cancerous and non-cancerous cells. That’s why many cancer patients experience so many troublesome side effects. It’s also why ... Read more
Less-frequent Pap smears may miss cancer precursors

Less-frequent Pap smears may miss cancer precursors

March 7, 2013 5:13 pm by | 0 Comments

NEW YORK (Reuters Health) - Certain types of cervical abnormalities that can lead to cancer may be missed when young women go years between Pap smears, a new study suggests.Last ... Read more